Latest Project Updates
Rs.105 Million New Active Pharmaceutical Ingredient Mfg. Unit in Ahmadabad, Gujarat
Executive Summary: A new pharmaceutical facility is being developed in Sanand, Ahmedabad, focusing on Active Pharmaceutical Ingredient (API) production with a 283.2 TPA capacity. The ₹105 million project is currently in the environmental clearance stage. Construction is scheduled to begin in January 2027 and conclude by April 2028, aiming to strengthen the regional bulk drug manufacturing ecosystem.
Rs.750 Million API & API Intermediates Mfg. Expansion Project in Bharuch, Gujarat
Executive Summary: A pharmaceutical company is expanding its manufacturing capacity in Bharuch, Gujarat, to increase the production of APIs and intermediates to 148.659 MT/month. With a Rs. 750 million investment, the project began in March 2026 and is slated for completion by August 2026. The facility upgrade is currently undergoing the mandatory environmental clearance process.
Rs.378000 Million New Green Amonia Project in Raigad/Palghar, Maharashtra
Executive Summary: A major green energy initiative is underway in Maharashtra to establish a large-scale facility dedicated to producing green ammonia. Backed by a substantial investment of Rs. 378,000 million, this project recently received state government approval. The initiative marks a significant step forward in developing large-scale sustainable chemical manufacturing and renewable hydrogen infrastructure to support global decarbonization efforts.
Rs.119 Million Pharma Products Mfg. Expansion Project in Solan, Himachal Pradesh
Executive Summary: A pharmaceutical manufacturer in Himachal Pradesh is expanding its production capacity for tablets and capsules from 91 million to 111 million units annually. This project, involving an investment of Rs. 119.7 million, received state approval in early 2026 and is currently under implementation, aimed at scaling operations to meet increasing market demand for pharmaceutical formulations.
Rs.275150 Million New Green Ammonia Project in Chhatrapati Sambhajinagar, Maharashtra
Executive Summary: A new large-scale manufacturing project in Chhatrapati Sambhajinagar, Maharashtra, received government approval in April 2026. With an investment of ₹27,515 crore, the facility is designed to generate 4,000 direct jobs. Strategically located within the Delhi-Mumbai Industrial Corridor, this development is set to accelerate regional industrialization, strengthen the local economy, and enhance advanced manufacturing infrastructure.
Rs.751 Million API Research and Development Unit in Sangareddy, Telangana
Executive Summary: A new API Research and Development facility is being established in Sangareddy, Telangana, with an estimated investment of ₹751.3 million. The project, which recently secured environmental "Consent to Establish" in April 2026, aims to focus on drug development and pharmaceutical innovation. This facility will significantly bolster the regional pharmaceutical sector's R&D infrastructure upon commencement of operations.
Rs.968 Million Chemical Mfg. Expansion Project in SPSR Nellore, Andhra Pradesh
Executive Summary: A chemical and biochemical manufacturing facility in SPSR Nellore, Andhra Pradesh, is undertaking a ₹968.9 million expansion project. Approved by state pollution authorities in April 2026, the initiative focuses on increasing production capacities for enzymes and pharmaceutical intermediates, including Tacrolimus and Oligosaccharide-A, to meet growing industrial demand and enhance the site's specialized manufacturing infrastructure.
Rs.150 Million Linear Alkyl Benzene Sulphonic Acid Mfg. Unit Expansion Project in Thoothukkudi, Tamil Nadu
Executive Summary: A major fertilizer manufacturer is expanding its industrial footprint in Thoothukkudi, Tamil Nadu, with a new 50,000 TPA LABSA production unit. With a Rs. 150 million investment and construction nearly finalized, the project is currently undergoing final environmental clearance. This expansion aims to significantly increase the domestic output of essential chemical intermediates for various industrial and consumer applications.
Pharma Products Mfg. Expansion Project in Solan, Himachal Pradesh
Executive Summary: A pharmaceutical manufacturer is expanding its Baddi facility with an Rs. 82 million investment. The project significantly scales production of tablets, capsules, syrups, protein powders, and eye/nasal drops. With state approvals granted in February 2026, site work has now commenced to enhance domestic manufacturing capacity and meet growing market demand for diverse healthcare formulations.
Rs.300 Million New Formulation Unit in Tirupati, Andhra Pradesh
Executive Summary: A pharmaceutical company is establishing a new formulation manufacturing facility in Tirupati, Andhra Pradesh. With a Rs. 300 million investment, the unit will produce tablets, capsules, ointments, and sachets. The project has officially received necessary environmental consent to establish as of April 2026, marking the commencement of this significant expansion in industrial pharmaceutical infrastructure.